Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 336 Patent - How do you spell relief?

< then why would PTSC choose not to issue a PR?>

Is that a trick question? I thought we discussed the master agreement here enough times to know it is TPL's call. If issuing a pr on the denial might be good for PTSC, it would not be in TPL's interest to do it.

I hope any settlement addresses this limitation. Is that where you were headed with the question?

Opty

Share
New Message
Please login to post a reply